| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 103,162 | |||
| Marketable securities | 39,421 | |||
| Prepaid expenses and other current assets | 4,949 | |||
| Total current assets | 147,532 | |||
| Operating lease right-of-use assets, net | 884 | |||
| Promissory note receivable from related party (note 8)-Related Party | 7,510 | |||
| Other non-current assets | 4,952 | |||
| Deferred offering costs | 0 | |||
| Total assets | 160,878 | |||
| Total redeemable convertible preferred shares | 0 | |||
| Accounts payable | 2,081 | |||
| Deferred revenue, current | 0 | |||
| Lease liabilities, current | 2,161 | |||
| Term loan | 0 | |||
| Accrued expenses and other current liabilities | 6,902 | |||
| Total current liabilities | 11,144 | |||
| Lease liabilities, non-current | 1,284 | |||
| Cvr liability due to related party (note 8)-Related Party | 7,510 | |||
| Other non-current liabilities | 1,108 | |||
| Total liabilities | 21,046 | |||
| Preferred stock value-Series AConvertible Preferred Stock | 0 | |||
| Preferred stock value | 0 | |||
| Common stock value-Voting Common Stock | 11 | |||
| Common stock value-Non-Voting Common Stock | 0 | |||
| Additional paid-in capital | 362,870 | |||
| Accumulated deficit | -223,143 | |||
| Accumulated other comprehensive income (loss) | 94 | |||
| Total stockholders' equity (deficit) | 139,832 | |||
| Total liabilities, redeemable convertible preferred shares and stockholders' equity (deficit) | 160,878 | |||
ImageneBio, Inc. (IMA)
ImageneBio, Inc. (IMA)